The University of Parma is a public university in Parma, Emilia-Romagna, Italy. It is organised in nine departments. As of 2016 the University of Parma has about 26,000 students.

During the past decade, University of Parma conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Parma" #1 sponsor was "University of Parma" with 8 trials, followed by "Galderma R&D" with 2 trials sponsored, "Catholic University of the Sacred Heart" with 1 trials sponsored, "Glycaemic Index Testing, Inc." with 1 trials sponsored and "HealthCore-NERI" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Parma" #1 collaborator was "Azienda Ospedaliero-Universitaria di Parma" with 2 trials as a collaborator, "IRCCS Policlinico S. Matteo" with 2 trials as a collaborator, "University of Parma" with 2 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator and "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Parma" are "Cardiovascular Disease" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Androgen Deficiency" (1 trials), "Aspergillosis" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "University of Parma" in a lesser frequency.

Most popular intervention types in "University of Parma" are "Drug" (4 trials), "Diagnostic Test" (3 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AOT" (1 trials), "Calcitriol" (1 trials), "Cream" (1 trials), "Intrapartum sonography" (1 trials) and "Inulin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Parma" are 17 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Parma". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Parma, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Parma, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".